Archives of Dermatological Research

, Volume 306, Issue 9, pp 781–791

Association of FCGR2A-R/H131 polymorphism with susceptibility to systemic lupus erythematosus among Asian population: a meta-analysis of 20 studies

  • Rui Li
  • Hui Peng
  • Gui-Mei Chen
  • Chen-Chen Feng
  • Yu-Jing Zhang
  • Peng-Fei Wen
  • Li-Juan Qiu
  • Rui-Xue Leng
  • Hai-Feng Pan
  • Dong-Qing Ye
Original Paper

Abstract

The results of studies on association between FCGR2A-R/H131 polymorphism and susceptibility to systemic lupus erythematosus (SLE) in the Asian population are controversial. To derive a more precise estimation on the genetic risk of FCGR2A-R/H131 variant for SLE in Asians, a meta-analysis was performed for genotypes R/R + R/H (dominant effect), R/R (recessive effect), and R allele in fixed/random effects models. Twenty studies involving 4,832 SLE patients and 6,190 controls were included. The meta-analysis showed that FCGR2A-R/H131 variant was associated with development of SLE in overall Asians both at allele or genotype level (R vs H, OR 1.201, 95 % CI 1.098–1.315; RR + RH vs HH, OR 1.369, 95 % CI 1.115–1.682; RR vs RH + HH, OR 1.305, 95 % CI 1.029–1.654). After stratification by ethnic, a significant association of R allele with susceptibility to SLE was observed in the Chinese population (R vs H, OR 1.104, 95 % CI 1.030–1.183). Evidence from subgroup analyses in non-Chinese populations (all Asians excluding Chinese population) also showed a significant association (R vs H, OR 1.354, 95 % CI 1.207–1.519; RR + RH vs HH, OR 1.705, 95 % CI 1.234–2.355). In addition, FCGR2A-R131 allele was associated with a 1.186-fold (95 % CI 1.043–1.349) greater risk for the occurrence of nephritis in the Asians population with SLE. After stratification by ethnic, this significant association was only consistently identified in non-Chinese populations (R vs H, OR 1.220, 95 % CI 1.002–1.486). In summary, FCGR2A-R/H131 polymorphism is associated with SLE and lupus nephritis in Asians.

Keywords

Systemic lupus erythematosus FCGR2A Polymorphism Meta-analysis 

Supplementary material

403_2014_1483_MOESM1_ESM.pdf (51 kb)
Supplementary material 1 (PDF 51 kb)

References

  1. 1.
    Arnett FC, Reveille JD (1992) Genetics of systemic lupus erythematosus. Rheum Dis Clin North Am 18(4):865–892PubMedGoogle Scholar
  2. 2.
    Botto M, Theodoridis E, Thompson EM, Beynon HL, Briggs D, Isenberg DA, Walport MJ, Davies KA (1996) Fc gamma RIIa polymorphism in systemic lupus erythematosus (SLE): no association with disease. Clin Exp Immunol 104(2):264–268PubMedCrossRefPubMedCentralGoogle Scholar
  3. 3.
    Chen JY, Wang CM, Tsao KC, Chow YH, Wu JM, Li CL, Ho HH, Wu YJ, Luo SF (2004) Fcgamma receptor IIa, IIIa, and IIIb polymorphisms of systemic lupus erythematosus in Taiwan. Ann Rheum Dis 63(7):877–880PubMedCrossRefPubMedCentralGoogle Scholar
  4. 4.
    Chu ZT, Tsuchiya N, Kyogoku C, Ohashi J, Qian YP, Xu SB, Mao CZ, Chu JY, Tokunaga K (2004) Association of Fcgamma receptor IIb polymorphism with susceptibility to systemic lupus erythematosus in Chinese: a common susceptibility gene in the Asian populations. Tissue Antigens 63(1):21–27PubMedCrossRefGoogle Scholar
  5. 5.
    Clark MR, Stuart SG, Kimberly RP, Ory PA, Goldstein IM (1991) A single amino acid distinguishes the high-responder from low responder form of Fc receptor II on human monocytes. Eur J Immunol 21(8):1911–1916PubMedCrossRefGoogle Scholar
  6. 6.
    Davies KA, Peters AM, Beynon HL, Walport MJ (1992) Immune complex processing in patients with systemic lupus erythematosus. In vivo imaging and clearance studies. J Clin Invest 90(5):2075–2083PubMedCrossRefPubMedCentralGoogle Scholar
  7. 7.
    DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188PubMedCrossRefGoogle Scholar
  8. 8.
    Dijstelbloem HM, Bijl M, Fijnheer R, Scheepers RH, Oost WW, Jansen MD, Sluiter WJ, Limburg PC, Derksen RH, van de Winkel JG, Kallenberg CG (2000) Fcgamma receptor polymorphisms in systemic lupus erythematosus: association with disease and in vivo clearance of immune complexes. Arthritis Rheum 43(12):2793–2800PubMedCrossRefGoogle Scholar
  9. 9.
    Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634PubMedCrossRefPubMedCentralGoogle Scholar
  10. 10.
    Fernando MM, Freudenberg J, Lee A, Morris DL, Boteva L, Rhodes B, Gonzalez-Escribano MF, Lopez-Nevot MA, Navarra SV, Gregersen PK, Martin J, IMAGEN, Vyse TJ (2012) Transancestral mapping of the MHC region in systemic lupus erythematosus identifies new independent and interacting loci at MSH5, HLA-DPB1 and HLA-G. Ann Rheum Dis 71(5):777–784PubMedCrossRefPubMedCentralGoogle Scholar
  11. 11.
    Frank MM, Hamburger MI, Lawley TJ, Kimberly RP, Plotz PH (1979) Defective reticuloendothelial system Fc-receptor function in systemic lupus erythematosus. N Engl J Med 300(10):518–523PubMedCrossRefGoogle Scholar
  12. 12.
    Han JW, Zheng HF, Ye Cui et al (2009) Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet 41(11):1234–1237PubMedCrossRefGoogle Scholar
  13. 13.
    Harley JB, Alarcón-Riquelme ME, Criswell LA et al (2008) Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 40(2):204–210PubMedCrossRefPubMedCentralGoogle Scholar
  14. 14.
    Hatta Y, Tsuchiya N, Ohashi J, Matsushita M, Fujiwara K, Hagiwara K, Juji T, Tokunaga K (1999) Association of Fc gamma receptor IIIB, but not of Fc gamma receptor IIA and IIIA polymorphisms with systemic lupus erythematosus in Japanese. Genes Immun 1(1):53–60PubMedCrossRefGoogle Scholar
  15. 15.
    Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558PubMedCrossRefGoogle Scholar
  16. 16.
    Hirankarn N, Wongpiyabovorn J, Hanvivatvong O, Netsawang J, Akkasilpa S, Wongchinsri J, Hanvivadhanakul P, Korkit W, Avihingsanon Y (2006) The synergistic effect of FC gamma receptor IIa and interleukin-10 genes on the risk to develop systemic lupus erythematosus in Thai population. Tissue Antigens 68(5):399–406PubMedCrossRefGoogle Scholar
  17. 17.
    Hom G, Graham RR, Modrek B, Taylor KE, Ortmann W, Garnier S, Lee AT, Chung SA, Ferreira RC, Pant PV, Ballinger DG, Kosoy R, Demirci FY, Kamboh MI, Kao AH, Tian C, Gunnarsson I, Bengtsson AA, Rantapää-Dahlqvist S, Petri M, Manzi S, Seldin MF, Rönnblom L, Syvänen AC, Criswell LA, Gregersen PK, Behrens TW (2008) Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med 358(9):900–909PubMedCrossRefGoogle Scholar
  18. 18.
    Jönsen A, Bengtsson AA, Sturfelt G, Truedsson L (2004) Analysis of HLA DR, HLA DQ, C4A, FcgammaRIIa, FcgammaRIIIa, MBL, and IL-1Ra allelic variants in Caucasian systemic lupus erythematosus patients suggests an effect of the combined FcgammaRIIa R/R and IL-1Ra 2/2 genotypes on disease susceptibility. Arthritis Res Ther 6(6):R557–R562PubMedCrossRefPubMedCentralGoogle Scholar
  19. 19.
    Karassa FB, Trikalinos TA, Ioannidis JP, FcgammaRIIa-SLE Meta-Analysis Investigators (2002) Role of the Fcgamma receptor IIa polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis. Arthritis Rheum 46(6):1563–1571PubMedCrossRefGoogle Scholar
  20. 20.
    Kelly JA, Kelley JM, Kaufman KM, Kilpatrick J, Bruner GR, Merrill JT, James JA, Frank SG, Reams E, Brown EE, Gibson AW, Marion MC, Langefeld CD, Li QZ, Karp DR, Wakeland EK, Petri M, Ramsey-Goldman R, Reveille JD, Vilá LM, Alarcón GS, Kimberly RP, Harley JB, Edberg JC (2008) Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African Americans. Genes Immun 9(3):187–194PubMedCrossRefGoogle Scholar
  21. 21.
    Khoa PD, Sugiyama T, Yokochi T (2003) Fc gamma receptor II polymorphism in Vietnamese patients with systemic lupus erythematosus. Lupus 12(9):704–706PubMedCrossRefGoogle Scholar
  22. 22.
    Kimberly RP, Salmon JE, Edberg JC (1995) Receptors for immunoglobulin G. Molecular diversity and implications for disease. Arthritis Rheum 38(3):306–314PubMedCrossRefGoogle Scholar
  23. 23.
    Kobayashi T, Ito S, Yasuda K, Kuroda T, Yamamoto K, Sugita N, Tai H, Narita I, Gejyo F, Yoshie H (2007) The combined genotypes of stimulatory and inhibitory Fc gamma receptors associated with systemic lupus erythematosus and periodontitis in Japanese adults. J Periodontol 78(3):467–474PubMedCrossRefGoogle Scholar
  24. 24.
    Kobayashi T, Ito S, Yamamoto K, Hasegawa H, Sugita N, Kuroda T, Kaneko S, Narita I, Yasuda K, Nakano M, Gejyo F, Yoshie H (2003) Risk of periodontitis in systemic lupus erythematosus is associated with Fcgamma receptor polymorphisms. J Periodontol 74(3):378–384PubMedCrossRefGoogle Scholar
  25. 25.
    Kozyrev SV, Abelson AK, Wojcik J, Zaghlool A, Linga Reddy MV, Sanchez E, Gunnarsson I, Svenungsson E, Sturfelt G, Jönsen A, Truedsson L, Pons-Estel BA, Witte T, D’Alfonso S, Barizzone N, Danieli MG, Gutierrez C, Suarez A, Junker P, Laustrup H, González-Escribano MF, Martin J, Abderrahim H, Alarcón-Riquelme ME (2008) Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nat Genet 40(2):211–216PubMedCrossRefGoogle Scholar
  26. 26.
    Kyogoku C, Dijstelbloem HM, Tsuchiya N, Hatta Y, Kato H, Yamaguchi A, Fukazawa T, Jansen MD, Hashimoto H, van de Winkel JG, Kallenberg CG, Tokunaga K (2002) Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility. Arthritis Rheum 46(5):1242–1254PubMedCrossRefGoogle Scholar
  27. 27.
    Lee HS, Chung YH, Kim TG, Kim TH, Jun JB, Jung S, Bae SC, Yoo DH (2003) Independent association of HLA-DR and FCgamma receptor polymorphisms in Korean patients with systemic lupus erythematosus. Rheumatology (Oxford) 42(12):1501–1507CrossRefGoogle Scholar
  28. 28.
    Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22(4):719–748PubMedGoogle Scholar
  29. 29.
    Mavridis D, Salanti G (2014) How to assess publication bias: funnel plot, trim-and-fill method and selection models. Evid Based Ment Health 17(1):30PubMedCrossRefGoogle Scholar
  30. 30.
    Moser KL, Neas BR, Salmon JE, Yu H, Gray-McGuire C, Asundi N, Bruner GR, Fox J, Kelly J, Henshall S, Bacino D, Dietz M, Hogue R, Koelsch G, Nightingale L, Shaver T, Abdou NI, Albert DA, Carson C, Petri M, Treadwell EL, James JA, Harley JB (1998) Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. Proc Natl Acad Sci USA 95(25):14869–14874PubMedCrossRefPubMedCentralGoogle Scholar
  31. 31.
    Ni PS, Shen FM, Meng W, Jiang F, Feng SF (2000) The association and linkage analysis between the FcγRIIa-131 and systemic lupus erythematosus. Chin J Med Genet 17(6):409–412 (in Chinese)Google Scholar
  32. 32.
    Norsworthy P, Theodoridis E, Botto M, Athanassiou P, Beynon H, Gordon C, Isenberg D, Walport MJ, Davies KA (1999) Overrepresentation of the Fcgamma receptor type IIA R131/R131 genotype in caucasoid systemic lupus erythematosus patients with autoantibodies to C1q and glomerulonephritis. Arthritis Rheum 42(9):1828–1832PubMedCrossRefGoogle Scholar
  33. 33.
    Pan HF, Ye DQ, Li XP (2008) Type 17 T-helper cells might be a promising therapeutic target for systemic lupus erythematosus. Nat Clin Pract Rheumatol 4(7):352–353PubMedGoogle Scholar
  34. 34.
    Qiu MT, Li XP, Mao CZ, Yang HY (2005) Study on the correlation between polymorphism distribution of FcγRIIA and SLE susceptibility. South China J Derm Venereol 12(2):82–87 (in Chinese)Google Scholar
  35. 35.
    Remmers EF, Plenge RM, Lee AT, Graham RR, Hom G, Behrens TW, de Bakker PI, Le JM, Lee HS, Batliwalla F, Li W, Masters SL, Booty MG, Carulli JP, Padyukov L, Alfredsson L, Klareskog L, Chen WV, Amos CI, Criswell LA, Seldin MF, Kastner DL, Gregersen PK (2007) STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 357(10):977–986PubMedCrossRefPubMedCentralGoogle Scholar
  36. 36.
    Sammaritano LR, Ng S, Sobel R, Lo SK, Simantov R, Furie R, Kaell A, Silverstein R, Salmon JE (1997) Anticardiolipin IgG subclasses: association of IgG2 with arterial and/or venous thrombosis. Arthritis Rheum 40(11):1998–2006PubMedCrossRefGoogle Scholar
  37. 37.
    Salmon JE, Millard S, Schachter LA, Arnett FC, Ginzler EM, Gourley MF, Ramsey-Goldman R, Peterson MG, Kimberly RP (1996) Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest 97(5):1348–1354PubMedCrossRefPubMedCentralGoogle Scholar
  38. 38.
    Salmon JE, Pricop L (2001) Human receptors for immunoglobulin G: key elements in the pathogenesis of rheumatic disease. Arthritis Rheum 44(4):739–750PubMedCrossRefGoogle Scholar
  39. 39.
    Sánchez E, Comeau ME, Freedman BI et al (2011) Identification of novel genetic susceptibility loci in African American lupus patients in a candidate gene association study. Arthritis Rheum 63(11):3493–3501PubMedCrossRefPubMedCentralGoogle Scholar
  40. 40.
    Sato H, Iwano M, Akai Y, Nishino T, Fujimoto T, Shiiki H, Dohi K (2001) FcgammaRIIa polymorphism in Japanese patients with systemic lupus erythematosus. Lupus 10(2):97–101PubMedCrossRefGoogle Scholar
  41. 41.
    Schur PH (1995) The genetics of systemic lupus erythematosus. Lupus 4(6):425–437PubMedCrossRefGoogle Scholar
  42. 42.
    Shen SK, Ren W, Han JW, Zhang X, Gao M, Cui Y, Sun LD, Zhou FS, Zheng HF, Yang JQ, Yang S, Zhang XJ (2009) Association between polymorphism of FCGR2A gene and systemic lupus erythematosus susceptibility in Chinese Han population. Acta Univ Med Anhui 44(3):334–336 (in Chinese)Google Scholar
  43. 43.
    Sigurdsson S, Nordmark G, Göring HH, Lindroos K, Wiman AC, Sturfelt G, Jönsen A, Rantapää-Dahlqvist S, Möller B, Kere J, Koskenmies S, Widén E, Eloranta ML, Julkunen H, Kristjansdottir H, Steinsson K, Alm G, Rönnblom L, Syvänen AC (2005) Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet 76(3):528–537PubMedCrossRefPubMedCentralGoogle Scholar
  44. 44.
    Siriboonrit U, Tsuchiya N, Sirikong M, Kyogoku C, Bejrachandra S, Suthipinittharm P, Luangtrakool K, Srinak D, Thongpradit R, Fujiwara K, Chandanayingyong D, Tokunaga K (2003) Association of Fcgamma receptor IIb and IIIb polymorphisms with susceptibility to systemic lupus erythematosus in Thais. Tissue Antigens 61(5):374–383PubMedCrossRefGoogle Scholar
  45. 45.
    Song YW, Han CW, Kang SW, Baek HJ, Lee EB, Shin CH, Hahn BH, Tsao BP (1998) Abnormal distribution of Fc gamma receptor type IIa polymorphisms in Korean patients with systemic lupus erythematosus. Arthritis Rheum 41(3):421–426PubMedCrossRefGoogle Scholar
  46. 46.
    Sun L, Shen N, Wang Y, Qian J, Bao CD, Gu YY, Chen SL (2004) Association between FCGR2A polymorphism and systemic lupus erythematosus. Chin J Rheumatol 8(1):1–3 (in Chinese)Google Scholar
  47. 47.
    Tsao BP (2000) Lupus susceptibility genes on human chromosome 1. Int Rev Immunol 19(4–5):319–334PubMedCrossRefGoogle Scholar
  48. 48.
    Warmerdam PA, van de Winkel JG, Vlug A, Westerdaal NA, Capel PJ (1991) A single amino acid in the second Ig-like domain of the human Fc gamma receptor II is critical for human IgG2 binding. J Immunol 147(4):1338–1343PubMedGoogle Scholar
  49. 49.
    Wisnieski JJ, Jones SM (1992) Comparison of autoantibodies to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome and systemic lupus erythematosus. J Immunol 148(5):1396–1403PubMedGoogle Scholar
  50. 50.
    Yang W, Shen N, Ye DQ et al (2010) Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus. PLoS Genet 6(2):e1000841PubMedCrossRefPubMedCentralGoogle Scholar
  51. 51.
    Yap SN, Phipps ME, Manivasagar M, Tan SY, Bosco JJ (1999) Human Fc gamma receptor IIA (FcgammaRIIA) genotyping and association with systemic lupus erythematosus (SLE) in Chinese and Malays in Malaysia. Lupus 8(4):305–310PubMedCrossRefGoogle Scholar
  52. 52.
    Yuan H, Pan HF, Li LH, Feng JB, Li WX, Li XP, Ye DQ (2009) Meta analysis on the association between FccRIIa-R/H131 polymorphisms and systemic lupus erythematosus. Mol Biol Rep 36(5):1053–1058PubMedCrossRefGoogle Scholar
  53. 53.
    Yun HR, Koh HK, Kim SS, Chung WT, Kim DW, Hong KP, Song GG, Chang HK, Choe JY, Bae SC, Salmon JE, Yoo DH, Kim TY, Kim SY (2001) FcgammaRIIa/IIIa polymorphism and its association with clinical manifestations in Korean lupus patients. Lupus 10(7):466–472PubMedCrossRefGoogle Scholar
  54. 54.
    Zhou XJ, Lv JC, Qin LX, Yang HZ, Yu F, Zhao MH, Zhang H (2011) Is FCGR2A a susceptibility gene to systemic lupus erythematosus in Chinese? Lupus 20(11):1198–1202PubMedCrossRefGoogle Scholar
  55. 55.
    Zuñiga R, Ng S, Peterson MG, Reveille JD, Baethge BA, Alarcón GS, Salmon JE (2001) Low-binding alleles of Fcgamma receptor types IIA and IIIA are inherited independently and are associated with systemic lupus erythematosus in Hispanic patients. Arthritis Rheum 44(2):361–367PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Rui Li
    • 1
    • 2
  • Hui Peng
    • 3
  • Gui-Mei Chen
    • 4
  • Chen-Chen Feng
    • 1
    • 2
  • Yu-Jing Zhang
    • 1
    • 2
  • Peng-Fei Wen
    • 1
    • 2
  • Li-Juan Qiu
    • 1
    • 2
  • Rui-Xue Leng
    • 1
    • 2
  • Hai-Feng Pan
    • 1
    • 2
  • Dong-Qing Ye
    • 1
    • 2
  1. 1.Department of Epidemiology and Biostatistics, School of Public HealthAnhui Medical UniversityHefeiPeople’s Republic of China
  2. 2.Anhui Provincial Laboratory of Population Health and Major Disease Screening and DiagnosisAnhui Medical UniversityHefeiPeople’s Republic of China
  3. 3.The First Affiliated Hospital of Wannan Medical CollegeWuhuPeople’s Republic of China
  4. 4.School of Health ManagementAnhui Medical UniversityHefeiPeople’s Republic of China

Personalised recommendations